Literature DB >> 2106499

Cervical-cancer screening: attendance and cost-effectiveness.

M A Koopmanschap1, G J van Oortmarssen, H M van Agt, M van Ballegooijen, J D Habbema, K T Lubbe.   

Abstract

The influence of attendance on the health effects and cost-effectiveness of cervical-cancer screening was studied, both for organized screening programmes and for spontaneous screening. The asymmetric distribution of smears among the female population and the higher risk incurred by women who never or only occasionally attend screening appear crucial in determining the health effects of screening. An increase in attendance rate induces a substantial rise in health effects and a less than proportionate rise in costs, thus improving cost-effectiveness. Wider screening coverage, in order to increase the number of life-years saved, is achieved more efficiently by encouraging a greater number of women to attend than by inviting the same number of women to attend more often, i.e., with a shorter interval between successive screens. Spontaneous screening is characterized by high coverage for younger women and low coverage for middle-aged and older women. This leads to a small amount of health effects and poor cost-effectiveness as compared with organized screening.

Entities:  

Mesh:

Year:  1990        PMID: 2106499     DOI: 10.1002/ijc.2910450305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  The screening history of women with cervical cancer in the Rotterdam area.

Authors:  F A Kreuger; H Beerman
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  The value of improving failures within a cervical cancer screening program: an example from Norway.

Authors:  Emily A Burger; Jane J Kim
Journal:  Int J Cancer       Date:  2014-03-20       Impact factor: 7.396

3.  Optimization of cervical cancer screening.

Authors:  L Gustafsson; H O Adami
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

4.  Preliminary results of a general practice based call system for cervical cancer screening in The Netherlands.

Authors:  B T Palm; A C Kant; W J van den Bosch; G P Vooijs; C van Weel
Journal:  Br J Gen Pract       Date:  1993-12       Impact factor: 5.386

Review 5.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

6.  Comparison of models for predicting outcomes in patients with coronary artery disease focusing on microsimulation.

Authors:  Masoud Amiri; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2012-08

7.  Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.

Authors:  M van Ballegooijen; M E van den Akker-van Marle; P G Warmerdam; C J Meijer; J M Walboomers; J D Habbema
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer.

Authors:  G J van Oortmarssen; J D Habbema
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

9.  Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.

Authors:  L Gustafsson; P Sparén; M Gustafsson; E Wilander; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.